Navigation Links
SPO Updates Shareholders on 2012 Corporate Strategy
Date:1/24/2012

NEW YORK, January 24, 2012 /PRNewswire/ --

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today an update to its shareholders on the Company's product and revenue generation strategy for fiscal 2012 primarily based on the completion of development and launch of a new range of consumer wellness devices.

SPO currently has three products in development stage which utilize the Company's proprietary intellectual property portfolio. SPO anticipates revenue generation via a recently contracted strategic distribution partner for its consumer wellness bracelet to commence during the second half of 2012.

The products under development are:

(i) A new and unique consumer wellness bracelet designed to measure a person's overall daily activity level, especially useful for the overweight or obese. The wellness bracelet, both for children and adults, contains  innovative features including display functionality and a time-piece which continuously measures the number of daily activities and calories burned against a recommended goal.

(ii) A sports and wellness wristwatch using SPO' vital sign technology for continuous heart rate measurement, which negates the need for the traditional chest-strap currently being used by most sports watch manufacturers. The ability to accurately and reliably measure heart-rate from the wrist area during motion has been a major challenge for the sports watch industry which typically required a chest-strap for acquiring continuous heart-rate readings.

(iii) An innovative home-baby monitoring device for continuous measurement of wellness information to the parent or caregiver, while the baby is sleeping. This parental reassurance tool gives the company a technological competitive edge in providing an innovative, high performance solution for a market application t
'/>"/>

SOURCE SPO Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EU
3. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
4. Warner Chilcott Successfully Completes Refinancing of Senior Secured Credit Facilities and Updates Full Year 2011 Financial Guidance
5. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
6. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Raises Target Price From $4.40 to $6.50
7. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
8. NEURO-BIOTECH CORPORATION: Updates and latest developments
9. China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
10. Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview
11. China-Biotics Provides Further Updates on Qingpu New Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... 27, 2014 New Q4-2014 incentives ... , an industry leading unified communication and collaboration ... agents to deliver cloud-based audio and web/video conferencing ... , With SoundConnect’s Q4 incentive partners ... and/or web conferencing licenses sold, now through December ...
(Date:10/27/2014)... EASTON, Mass. , Oct. 27, 2014 /PRNewswire/ ... the "Company"), a worldwide leader in the development ... to the life sciences research market, today announced ... team presented a novel, accurate, highly reproducible, and ... time – routine high-throughput protein analysis on small ...
(Date:10/26/2014)... The report "Data Center Networking ... Equipment, WAN Optimization Appliances]: Global Advancements, Worldwide Forecasts ... center networking market into various segments with an ... also identifies the factors driving this market, various ... with the future roadmaps. , Browse 106 market ...
(Date:10/25/2014)... October 23, 2014 ViaDerma, ... pharmaceutical company devoted to bringing new products to ... 2015. , ViaDerma has developed an innovative, patent-pending ... rapid mass transfer of pharmaceutical active ingredients to ... provide immediate localized therapy. The transdermal delivery method ...
Breaking Biology Technology:SoundConnect Unveils Q4 Partner Incentives 2Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 2Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 3Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 4Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 5Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 2Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 3Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
... Aug. 1 Medivation, Inc.,(Nasdaq: MDVN ) today ... will present at the BMO Capital Markets 2008 Focus ... Eastern Time at,the Millennium Broadway Hotel in New York., ... and its clinical,development programs for Dimebon for Alzheimer,s and ...
... LITTLE FALLS, N.J., Aug. 1 CANTEL MEDICAL,CORP. ... its Crosstex,International, Inc. subsidiary, effective today. As planned, ... Crosstex, retired effective today,after over 50 years with ... company. Gary Steinberg and Mitchell Steinberg, also,former owners ...
... ROCKVILLE, Md., Aug. 1 Novavax, Inc. (Nasdaq:,NVAX) ... announced,registered direct equity financing of $18 million by ... existing shelf registration statement.,The Company sold 6,686,650 units ... affiliates of the Company. Each unit was comprised,of ...
Cached Biology Technology:Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5 2Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary 2Novavax Announces Closing of $18 Million Registered Direct Offering 2Novavax Announces Closing of $18 Million Registered Direct Offering 3
(Date:10/30/2014)... 2014 Biological membranes are mainly composed of lipid ... solution ions onto lipid membranes helps clarify functional ... provides a quantitative description of the equilibria between ... and Zbigniew Figaszewski from the University of Bialystok, ... these findings, just published in EPJ E ...
(Date:10/29/2014)... to date, researchers have used DNA sequencing to uncover ... Joseph Buxbaum, Ph.D., Icahn School of Medicine at Mount ... of Harvard and MIT, and their colleagues examined more ... unrelated people. They identified changes in 107 genes that ... spectrum disorder (ASD) – a jump from the nine ...
(Date:10/29/2014)... to make their food, but they also need protection from ... a group of molecules in plants that shields them from ... of the American Chemical Society , one team reports on ... Timothy Zwier and colleagues at Purdue University note that the ... serious damage to plant DNA and, as a result, hinder ...
Breaking Biology News(10 mins):Ion adsorption matter in biology 2
... model suggests that inhospitable hydrodgen-sulphide rich waters could have ... oceans. The research, published online this week in the ... the oceans 550-700 million years ago and shows that ... of complex life, were controlled by the biological availability ...
... hybrid nanomaterials, i.e. combinations of synthetic polymers and inorganic (gold, ... at the University of Helsinki in April. Part of ... a billionth of a metre, matter and materials behave in ... known what types of effects the nano version of the ...
... 200-plus research universities that make up ScienceWorksForU.S. today again ... across-the-board cuts to discretionary spending that will result in ... The consequences to the U.S. economy of reduced R&D ... reduction in U.S. GDP over the next nine years ...
Cached Biology News:Toxic oceans may have delayed spread of complex life 2Is nanosilver toxic? 2Is nanosilver toxic? 3Sequester will have a devastating impact on america's research enterprise 2Sequester will have a devastating impact on america's research enterprise 3
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C....
... Tyrosine Hydroxylase (Ser40) Polyclonal Antibody ... against synthetic phosphopeptide corresponding to ... phospho-Ser40 of rat Tyrosine Hydroxylase ... by sequential chromatography on phospho- ...
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
Biotin anti-human CD164...
Biology Products: